SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001447028-23-000074
Filing Date
2023-07-13
Accepted
2023-07-13 16:11:03
Documents
3
Period of Report
2023-07-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1689279052.html 3  
1 FORM 3 wk-form3_1689279052.xml 3 1666
2 EX-24 poa-rewolinski.htm EX-24 3803
3 poa-rewolinski001.jpg GRAPHIC 233148
  Complete submission text file 0001447028-23-000074.txt   328206
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9000 STATE ROAD PHILADELPHIA PA 19136
Business Address
Rewolinski Melissa (Reporting) CIK: 0001780206 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 231086874